Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Language
Year range
1.
Rev. Soc. Bras. Med. Trop ; 49(2): 196-203, Mar.-Apr. 2016. tab, graf
Article in English | LILACS | ID: lil-782098

ABSTRACT

Abstract: INTRODUCTION: Leishmaniasis is a disease caused by the protozoan Leishmania that resides mainly in mononuclear phagocytic system tissues. Pentavalent antimonials are the main treatment option, although these drugs have toxic side effects and high resistance rates. A potentially alternative and more effective therapeutic strategy is to use liposomes as carriers of the antileishmanial agents. The aims of this study were to develop antimonial drugs entrapped into phosphatidylserine liposomes and to analyze their biological and physicochemical characteristics. METHODS: Liposomes containing meglumine antimoniate (MA) or pentavalent antimony salt (Sb) were obtained through filter extrusion (FEL) and characterized by transmission electron microscopy. Promastigotes of Leishmania infantum were incubated with the drugs and the viability was determined with a tetrazolium dye (MTT assay). The effects of these drugs against intracellular amastigotes were also evaluated by optical microscopy, and mammalian cytotoxicity was determined by an MTT assay. RESULTS: Liposomes had an average diameter of 162nm. MA-FEL showed inhibitory activity against intracellular L. infantum amastigotes, with a 50% inhibitory concentration (IC50) of 0.9μg/mL, whereas that of MA was 60μg/mL. Sb-FEL showed an IC50 value of 0.2μg/mL, whereas that of free Sb was 9μg/mL. MA-FEL and Sb-FEL had strong in vitro activity that was 63-fold and 39-fold more effective than their respective free drugs. MA-FEL tested at a ten-times higher concentration than Sb-FEL did not show cytotoxicity to mammalian cells, resulting in a higher selectivity index. CONCLUSIONS: Antimonial drug-containing liposomes are more effective against Leishmania-infected macrophages than the non-liposomal drugs.


Subject(s)
Animals , Organometallic Compounds/pharmacology , Phosphatidylserines/pharmacology , Macrophages, Peritoneal/parasitology , Leishmania infantum/drug effects , Antimony Sodium Gluconate/pharmacology , Meglumine/pharmacology , Antiprotozoal Agents/pharmacology , Organometallic Compounds/chemistry , Phosphatidylserines/chemistry , Cricetinae , Antimony Sodium Gluconate/chemistry , Inhibitory Concentration 50 , Parasitic Sensitivity Tests , Dose-Response Relationship, Drug , Meglumine Antimoniate , Liposomes , Meglumine/chemistry , Mice , Mice, Inbred BALB C , Antiprotozoal Agents/chemistry
2.
Acta physiol. pharmacol. ther. latinoam ; 42(3): 183-96, 1992. tab, graf
Article in English | LILACS | ID: lil-134661

ABSTRACT

Cytosol (C) (100,000 x g/60 min, supernatant) from liver, brain and testis (Wistar male rats) are shown to contain insulin degrading activity (C-IDA). The regulation of C-IDA in these fractions by ligands that activate G protein and PKC were examined C-IDA from liver, brain and testis was inhibited 76%; 64% and 50% by 50 mM F- respectively. Chromatography of C fraction from liver on Sephadex G-50 in presence of 1 M (NH4)2SO4 and 20% (v/v) glycerol (experimental condition to remove guanine nucleotides from G proteins) decreased in about 3-fold aluminum fluoride effect on C-IDA. Mg++ (from 5mM to 10 mM) enhanced fluoride effects by inhibiting fully C-IDA. Phosphatidylserine in presence of ATP completely inhibited C-IDA; this inhibition was 31.3% mediated by a phosphorylation reaction. It is concluded that cytosol from different tissues contain proteins capable to associate ligands as aluminum fluoride and PS to regulate C-IDA. It is proposed a mechanism of protein-protein interaction to modulate C-IDA


Subject(s)
Animals , Male , Cytosol/metabolism , Fluorides/pharmacology , In Vitro Techniques , Insulin/metabolism , Phosphatidylserines/pharmacology , Adenosine Triphosphate/pharmacology , Ammonium Sulfate/pharmacology , Brain/drug effects , Brain/metabolism , Cytosol/drug effects , Depression, Chemical , GTP-Binding Proteins/metabolism , Iodine Radioisotopes , Liver/drug effects , Liver/metabolism , Magnesium/pharmacology , Protein Kinase C/metabolism , Rats , Rats, Wistar , Swine , Testis/drug effects , Testis/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL